The Capital Market Authority’s (CMA) Board of Directors approved today, March 26, the request of Specialized Medical Co. to register and offer 75 million shares for public subscription on the Main Market (TASI).
The offered shares represent 30% of the company’s total 250 million shares.
The CMA stated that the prospectus will be published well ahead of the subscription period.
The approval remains valid for six months from the board’s decision date and will be revoked if the company fails to complete the offering and listing within this period.
The Capital Market Authority’s (CMA) Board of Directors approved today, March 26, the request of Specialized Medical Co. to register and offer 75 million shares for public subscription on the Main Market (TASI).
The offered shares represent 30% of the company’s total 250 million shares.
The CMA stated that the prospectus will be published well ahead of the subscription period.
The approval remains valid for six months from the board’s decision date and will be revoked if the company fails to complete the offering and listing within this period.
